Results 201 to 210 of about 482,975 (382)
Neck‐vein thrombosis during spaceflight
British Journal of Clinical Pharmacology, EarlyView.Spaceflight imposes unique environmental challenges, including weightlessness, increased radiation exposure and confinement, which can lead to unexpected health effects. One such example is neck‐vein thrombosis, a condition rarely seen on Earth without predisposing factors such as venous catheters or infections.
Ulrich Limper, Jens Jordan
wiley +1 more source
Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use [PDF]
, 2023 Eric Duong +5 more
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky +9 more
wiley +1 more source
Why it is important to use the correct dose of the non-vitamin K oral anticoagulants [PDF]
, 2014 Bart Jacobs, Rik Willems, C. Garweg
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To translate a PBPK model developed for the direct oral anticoagulant, dabigatran etexilate, the prodrug of dabigatran, based on data obtained from healthy men to healthy non‐pregnant, pregnant and post‐partum women. To evaluate safety and efficacy of dabigatran etexilate in post‐partum women using simulations and design a future clinical study to
Kayode Ogungbenro +3 more
wiley +1 more source
WCN24-409 EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NEPHROTIC SYNDROME: A MULTI-INSTITUTIONAL ANALYSIS [PDF]
Brittany Miles, Aun Munis, Ankit Mehta
openalex +1 more source
Price Elasticity of Demand for New Oral Anticoagulant Agents among Patients with Non-Valvular Atrial Fibrillation [PDF]
, 2016 S Liu +4 more
openalex +1 more source
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer
British Journal of Clinical Pharmacology, EarlyView.Aims Treatment with enzalutamide in prostate cancer is challenging due to its high potential for drug–drug interactions, particularly in the typically older population of patients with frequent comorbidities treated with multiple drugs, such as anticoagulants.
Catharina J. P. Op 't Hoog +8 more
wiley +1 more source